Quote For Biogen Idec Inc. BIIB.O
sector: Healthcare ·
industry: Biotechnology ·
As of
3:30pm GMT
47.40USD
$47.40
3:30pm GMT
+0.98%
$46.94
$47.10
526,454
$47.59
$46.94
$55.34
$39.01
0.60
3,006,243
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Ross, Bruce |
Non-Executive Chairman of the Board |
-- |
| Mullen, James |
President, Chief Executive Officer, Director |
8,970,980 |
| Clancy, Paul |
Chief Financial Officer, Executive Vice President - Finance |
1,363,070 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$13,574.98 |
| Shares Outstanding (Mil.) |
289.20 |
| Float (Mil.) |
287.10 |
| |
| Dividend Information |
| Yield % |
-99,999.99 |
| Annual Dividend ($ USD) |
0.00 |
| Payout Ratio(TTM) % |
0.00 |
| |
| Financial Strength |
| Quick Ratio |
2.38 |
| Current Ratio |
3.57 |
| LT Debt/Equity |
16.54 |
| Total Debt/Equity |
16.78 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
15.70 |
| Price/Sales(TTM) |
3.14 |
| Price/Book(TTM) |
2.07 |
| Price/Cash Flow(TTM) |
10.18 |
| |
|
| Per Share Data |
| Earnings(TTM) |
$3.01 |
| Sales(TTM) |
$14.85 |
| Book Value(MRQ) |
$22.70 |
| Cash Flow(TTM) |
$4.58 |
| Cash(MRQ) |
$4.87 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
14.10 |
| Return on Assets(TTM) |
10.00 |
| Return on Investment(TTM) |
11.10 |
| |
|
| Margins |
| Gross Margin(TTM) % |
90.94 |
| Operating Margin(TTM) % |
28.41 |
| Profit Margin(TTM) % |
20.32 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives